SGMO
Sangamo Therapeutics, IncCompany with tickers: SGMO
CIK
1001233
CUSIP
800677106
Shares Outstanding
414,288,847
13F Activity (30d)
65 filings
63 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-09-14 | 2020-09-09 | |
| 10-Q | 2020-08-05 | 2020-06-30 | |
| 8-K | 2020-08-05 | — | |
| 8-K | 2020-07-30 | 2020-07-27 | |
| 8-K | 2020-06-24 | 2020-06-18 | |
| 8-K | 2020-06-18 | — | |
| 8-K/A | 2020-06-18 | — | |
| 8-K | 2020-05-22 | 2020-05-18 | |
| 8-K | 2020-05-11 | — | |
| 10-Q | 2020-05-11 | 2020-03-31 | |
| 8-K | 2020-04-17 | 2020-04-13 | |
| 8-K | 2020-02-28 | — | |
| 10-K | 2020-02-28 | 2019-12-31 | |
| 8-K | 2020-02-14 | 2020-02-11 |
Showing 101–114 of 114 filings